$1.19
0.19.17%
At close: -
$1.22
0.032.52%
After Hours: 7:50 PM EDT
Comments
Loading...
FibroBiologics Analyst Ratings and Price Targets | NASDAQ:FBLG | Benzinga
FibroBiologics Inc has a consensus price target of $13.6 based on the ratings of 5 analysts. The high is $16 issued by D. Boral Capital on April 9, 2025. The low is $12 issued by HC Wainwright & Co. on April 1, 2025. The 3 most-recent analyst ratings were released by D. Boral Capital, HC Wainwright & Co., and D. Boral Capital on April 9, 2025, April 1, 2025, and April 1, 2025, respectively. With an average price target of $14.67 between D. Boral Capital, HC Wainwright & Co., and D. Boral Capital, there's an implied 1102.19% upside for FibroBiologics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
D. Boral Capital
HC Wainwright & Co.
Rodman & Renshaw
EF Hutton
Maxim Group
1calculated from analyst ratings
Analyst Ratings for FibroBiologics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/09/2025 | Buy Now | 1211.48% | D. Boral Capital | Jason Kolbert42% | $16 → $16 | Maintains | Buy | Get Alert |
| 04/01/2025 | Buy Now | 883.61% | HC Wainwright & Co. | Matthew Caufield36% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | Buy Now | 1211.48% | D. Boral Capital | Jason Kolbert42% | $16 → $16 | Maintains | Buy | Get Alert |
| 03/04/2025 | Buy Now | 1211.48% | D. Boral Capital | Jason Kolbert42% | $16 → $16 | Maintains | Buy | Get Alert |
| 02/27/2025 | Buy Now | 1211.48% | D. Boral Capital | Jason Kolbert42% | $16 → $16 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 1211.48% | D. Boral Capital | Jason Kolbert42% | $16 → $16 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 883.61% | HC Wainwright & Co. | Matthew Caufield36% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 12/27/2024 | Buy Now | 1211.48% | D. Boral Capital | Jason Kolbert42% | $16 → $16 | Maintains | Buy | Get Alert |
| 12/12/2024 | Buy Now | 883.61% | Rodman & Renshaw | Elemer Piros55% | → $12 | Initiates | → Buy | Get Alert |
| 11/20/2024 | Buy Now | 1211.48% | D. Boral Capital | Jason Kolbert42% | $16 → $16 | Maintains | Buy | Get Alert |
| 11/13/2024 | Buy Now | 1211.48% | D. Boral Capital | Jason Kolbert42% | $16 → $16 | Maintains | Buy | Get Alert |
| 11/13/2024 | Buy Now | 883.61% | HC Wainwright & Co. | Matthew Caufield36% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 10/30/2024 | Buy Now | 883.61% | HC Wainwright & Co. | Matthew Caufield36% | → $12 | Initiates | → Buy | Get Alert |
| 10/18/2024 | Buy Now | 1211.48% | EF Hutton | Jason Kolbert42% | $16 → $16 | Maintains | Buy | Get Alert |
| 09/24/2024 | Buy Now | 883.61% | Maxim Group | Michael Okunewitch25% | → $12 | Initiates | → Buy | Get Alert |
| 09/13/2024 | Buy Now | 1211.48% | EF Hutton | Jason Kolbert42% | $16 → $16 | Maintains | Buy | Get Alert |
| 09/04/2024 | Buy Now | 1211.48% | EF Hutton | Jason Kolbert42% | → $16 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for FibroBiologics (FBLG) stock?
The latest price target for FibroBiologics (NASDAQ:FBLG) was reported by D. Boral Capital on April 9, 2025. The analyst firm set a price target for $16.00 expecting FBLG to rise to within 12 months (a possible 1211.48% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for FibroBiologics (FBLG)?
The latest analyst rating for FibroBiologics (NASDAQ:FBLG) was provided by D. Boral Capital, and FibroBiologics maintained their buy rating.
When was the last upgrade for FibroBiologics (FBLG)?
There is no last upgrade for FibroBiologics
When was the last downgrade for FibroBiologics (FBLG)?
There is no last downgrade for FibroBiologics.
When is the next analyst rating going to be posted or updated for FibroBiologics (FBLG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of FibroBiologics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for FibroBiologics was filed on April 9, 2025 so you should expect the next rating to be made available sometime around April 9, 2026.
Is the Analyst Rating FibroBiologics (FBLG) correct?
While ratings are subjective and will change, the latest FibroBiologics (FBLG) rating was a maintained with a price target of $16.00 to $16.00. The current price FibroBiologics (FBLG) is trading at is $1.22, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
